did serena williams use glp-1 on Why She Chose to Medication Could Serena Williams' GLP-1 Disclosure

Wegovy is now indicated for reduction of cardiovascular event, which means some payers that previously did not cover the drug for obesity now cover it for cardiovascular disease

A total of 61% said they've stopped ordering sugary beverages such as soda or sweet tea

At Seasons in Malibu, our clinical team treats both conditions at the same time, because they develop together and they need to heal together

Its really nice because it helped me stop drinking and it helped me get my appetite under control with less eating, he said

Metabolic disorders such as hypertension and dyslipidemia are considered to be risk factors that put the patient at an increased risk for cardiovascular disease